News
-
-
-
-
PRESS RELEASE
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion leading to EUR 100,000 capital increase. Oxurion issues 6,230,425 new ordinary shares as part of the Capital Commitment with Atlas Special Opportunities, LLC -
-
PRESS RELEASE
Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis
Oxurion NV announces the signing of a letter of intent to acquire a majority stake in a French Contract Research Organization (CRO) specialized in clinical development and regulatory affairs, enhancing its capabilities and services -
-
-
-
PRESS RELEASE
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion, leading to EUR 100,000 capital increase. Oxurion issues 5,990,086 new ordinary shares as part of EUR 20m Capital Commitment with Atlas. Company's total outstanding shares now 56,367,609